These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 32075932)
41. In vitro and in silico studies reveal capsid-mutant Porcine circovirus 2b with novel cytopathogenic and structural characteristics. Cruz TF; Magro AJ; de Castro AMMG; Pedraza-Ordoñez FJ; Tsunemi MH; Perahia D; Araujo JP Virus Res; 2018 Jun; 251():22-33. PubMed ID: 29730308 [TBL] [Abstract][Full Text] [Related]
42. Protective immunity conferred by porcine circovirus 2 ORF2-based DNA vaccine in mice. Sylla S; Cong YL; Sun YX; Yang GL; Ding XM; Yang ZQ; Zhou YL; Yang M; Wang CF; Ding Z Microbiol Immunol; 2014 Jul; 58(7):398-408. PubMed ID: 24845706 [TBL] [Abstract][Full Text] [Related]
43. Genetic variation and phylogenetic analysis of Porcine circovirus type 2 in China from 2016 to 2018. Hou Z; Wang H; Feng Y; Song M; Li Q; Li J Acta Virol; 2019; 63(4):459-468. PubMed ID: 31802689 [TBL] [Abstract][Full Text] [Related]
44. Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins. Fort M; Sibila M; Allepuz A; Mateu E; Roerink F; Segalés J Vaccine; 2008 Feb; 26(8):1063-71. PubMed ID: 18237827 [TBL] [Abstract][Full Text] [Related]
45. Assessment of neutralizing and non-neutralizing antibody responses against Porcine circovirus 2 in vaccinated and non-vaccinated farmed pigs. Solis Worsfold C; Dardari R; Law S; Eschbaumer M; Nourozieh N; Marshall F; Czub M J Gen Virol; 2015 Sep; 96(9):2743-2748. PubMed ID: 26033118 [TBL] [Abstract][Full Text] [Related]
46. Immunogenicity Evaluation of Modified Adenovirus Vaccines Expressing Porcine Circovirus Type 2 Capsid Protein in Pigs. Li D; Xu D; Wang Z; Du Q; Chang L; Zhao X; Huang Y; Tong D Viral Immunol; 2017 Mar; 30(2):111-119. PubMed ID: 27996636 [TBL] [Abstract][Full Text] [Related]
47. Porcine MKRN1 Modulates the Replication and Pathogenesis of Porcine Circovirus Type 2 by Inducing Capsid Protein Ubiquitination and Degradation. Wang T; Du Q; Wu X; Niu Y; Guan L; Wang Z; Zhao X; Liu SL; Tong D; Huang Y J Virol; 2018 Jun; 92(11):. PubMed ID: 29514908 [TBL] [Abstract][Full Text] [Related]
48. Utilization of phage display to identify antigenic regions in the PCV2 capsid protein for the evaluation of serological responses in mice and pigs. Santos MR; Assao VS; Santos FAA; Salgado RL; Carneiro AP; Fietto JLR; Bressan GC; de Almeida MR; Lobato ZIP; Ueira-Veira C; Goulart LR; Silva-Júnior A Arch Virol; 2018 Jul; 163(7):1877-1887. PubMed ID: 29589172 [TBL] [Abstract][Full Text] [Related]
49. Cellular p32 Is a Critical Regulator of Porcine Circovirus Type 2 Nuclear Egress. Wang T; Du Q; Niu Y; Zhang X; Wang Z; Wu X; Yang X; Zhao X; Liu SL; Tong D; Huang Y J Virol; 2019 Dec; 93(23):. PubMed ID: 31511386 [TBL] [Abstract][Full Text] [Related]
50. Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition. Trible BR; Ramirez A; Suddith A; Fuller A; Kerrigan M; Hesse R; Nietfeld J; Guo B; Thacker E; Rowland RR Vaccine; 2012 Jun; 30(27):4079-85. PubMed ID: 22521847 [TBL] [Abstract][Full Text] [Related]
51. Porcine Circovirus Type 2 (PCV2) Vaccines in the Context of Current Molecular Epidemiology. Karuppannan AK; Opriessnig T Viruses; 2017 May; 9(5):. PubMed ID: 28481275 [TBL] [Abstract][Full Text] [Related]
52. Porcine Circovirus 2 Uses a Multitude of Weak Binding Sites To Interact with Heparan Sulfate, and the Interactions Do Not Follow the Symmetry of the Capsid. Dhindwal S; Avila B; Feng S; Khayat R J Virol; 2019 Mar; 93(6):. PubMed ID: 30602608 [TBL] [Abstract][Full Text] [Related]
53. In vitro expression, monoclonal antibody and bioactivity for capsid protein of porcine circovirus type II without nuclear localization signal. Zhou JY; Shang SB; Gong H; Chen QX; Wu JX; Shen HG; Chen TF; Guo JQ J Biotechnol; 2005 Aug; 118(2):201-11. PubMed ID: 15964652 [TBL] [Abstract][Full Text] [Related]
54. Prevalence and phylogenetic analysis of the current porcine circovirus 2 genotypes after implementation of widespread vaccination programmes in the USA. Shen HG; Halbur PG; Opriessnig T J Gen Virol; 2012 Jun; 93(Pt 6):1345-1355. PubMed ID: 22398315 [TBL] [Abstract][Full Text] [Related]
55. Enhanced protective immune response to PCV2 adenovirus vaccine by fusion expression of Cap protein with InvC in pigs. Zhang Z; Luo Y; Zhang Y; Guo K J Vet Sci; 2019 Jul; 20(4):e35. PubMed ID: 31364320 [TBL] [Abstract][Full Text] [Related]
56. Generation and immunogenicity assessment of ELPylated virus-like particles of porcine circovirus type 2. Li Y; Wang Y; Cheng J; Zhou X; Lu H; Zhang X; Xia X; Sun H Virol J; 2020 Jun; 17(1):72. PubMed ID: 32517704 [TBL] [Abstract][Full Text] [Related]
57. Structural characterization of the PCV2d virus-like particle at 3.3 Å resolution reveals differences to PCV2a and PCV2b capsids, a tetranucleotide, and an N-terminus near the icosahedral 3-fold axes. Khayat R; Wen K; Alimova A; Gavrilov B; Katz A; Galarza JM; Gottlieb P Virology; 2019 Nov; 537():186-197. PubMed ID: 31505320 [TBL] [Abstract][Full Text] [Related]
58. Epitope screening of the PCV2 Cap protein by use of a random peptide-displayed library and polyclonal antibody. Ge M; Yan A; Luo W; Hu YF; Li RC; Jiang DL; Yu XL Virus Res; 2013 Oct; 177(1):103-7. PubMed ID: 23845304 [TBL] [Abstract][Full Text] [Related]
59. Characterization and epitope mapping of monoclonal antibodies recognizing N-terminus of Rep of porcine circovirus type 2. Meng T; Jia Q; Liu S; Karuppannan AK; Chang CC; Kwang J J Virol Methods; 2010 May; 165(2):222-9. PubMed ID: 20152863 [TBL] [Abstract][Full Text] [Related]
60. Structure analysis of capsid protein of Porcine circovirus type 2 from pigs with systemic disease. Gava D; Serrão VHB; Fernandes LT; Cantão ME; Ciacci-Zanella JR; Morés N; Schaefer R Braz J Microbiol; 2018; 49(2):351-357. PubMed ID: 29128395 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]